To Top
0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z


The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.

Vascular Birthmarks Foundation


P.O. Box 106
Latham, NY 12110 USA

800 Number


Email Address

[email protected]


The Hemangioma and Vascular Birthmarks Foundation is a non-profit organization of parents and professionals dedicated to providing information, assistance, and support to those affected by hemangiomas or other vascular birthmarks or tumors. Hemangiomas, the most common benign tumor affecting infants, are bluish or reddish flat or raised areas that are usually apparent at or within weeks after birth. Hemangiomas typically continue to grow for approximately one to two years and then begin a slow regression cycle. Vascular malformations are benign vascular lesions that are present at birth; however, in some cases, they may not become apparent for days, weeks, or even years after birth. Vascular malformations typically grow slowly and steadily throughout life with no regression cycle. The Hemangioma and Vascular Birthmarks Foundation is dedicated to educating physicians and other healthcare providers in the diagnosis and management of all vascular birthmarks; providing support, information, and referrals for all affected individuals; developing research projects concerning vascular birthmarks; and working toward the establishment of a uniform protocol for the diagnosis and treatment of vascular birthmarks.

Please Note

The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and the credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions is strictly prohibited.

NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.